412 related articles for article (PubMed ID: 31954207)
1. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
Namineni S; O'Connor T; Faure-Dupuy S; Johansen P; Riedl T; Liu K; Xu H; Singh I; Shinde P; Li F; Pandyra A; Sharma P; Ringelhan M; Muschaweckh A; Borst K; Blank P; Lampl S; Neuhaus K; Durantel D; Farhat R; Weber A; Lenggenhager D; Kündig TM; Staeheli P; Protzer U; Wohlleber D; Holzmann B; Binder M; Breuhahn K; Assmus LM; Nattermann J; Abdullah Z; Rolland M; Dejardin E; Lang PA; Lang KS; Karin M; Lucifora J; Kalinke U; Knolle PA; Heikenwalder M
J Hepatol; 2020 May; 72(5):960-975. PubMed ID: 31954207
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways.
Johnson DM; Khakhum N; Wang M; Warner NL; Jokinen JD; Comer JE; Lukashevich IS
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675975
[TBL] [Abstract][Full Text] [Related]
4. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.
Li W; Hofer MJ; Jung SR; Lim SL; Campbell IL
J Virol; 2014 Jul; 88(13):7578-88. PubMed ID: 24760883
[TBL] [Abstract][Full Text] [Related]
5. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
6. The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection.
Droebner K; Klein B; Paxian S; Schmid R; Stitz L; Planz O
Viral Immunol; 2010 Jun; 23(3):295-308. PubMed ID: 20565293
[TBL] [Abstract][Full Text] [Related]
7. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
[TBL] [Abstract][Full Text] [Related]
9. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
[TBL] [Abstract][Full Text] [Related]
10. A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
Le Bon A; Montoya M; Edwards MJ; Thompson C; Burke SA; Ashton M; Lo D; Tough DF; Borrow P
Eur J Immunol; 2006 Aug; 36(8):2085-93. PubMed ID: 16810633
[TBL] [Abstract][Full Text] [Related]
11. Role of PKR and Type I IFNs in viral control during primary and secondary infection.
Nakayama Y; Plisch EH; Sullivan J; Thomas C; Czuprynski CJ; Williams BR; Suresh M
PLoS Pathog; 2010 Jun; 6(6):e1000966. PubMed ID: 20585572
[TBL] [Abstract][Full Text] [Related]
12. Mast Cells Modulate Antigen-Specific CD8
Hackler Y; Siebenhaar F; Löhning M; Maurer M; Muñoz M
Front Immunol; 2021; 12():688347. PubMed ID: 34194439
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.
Lee MS; Park CH; Jeong YH; Kim YJ; Ha SJ
PLoS Pathog; 2013; 9(7):e1003478. PubMed ID: 23874199
[TBL] [Abstract][Full Text] [Related]
14. Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation.
Shaabani N; Khairnar V; Duhan V; Zhou F; Tur RF; Häussinger D; Recher M; Tumanov AV; Hardt C; Pinschewer D; Christen U; Lang PA; Honke N; Lang KS
J Autoimmun; 2016 Feb; 67():82-89. PubMed ID: 26553386
[TBL] [Abstract][Full Text] [Related]
15. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice.
Li W; Hofer MJ; Noçon AL; Manders P; Campbell IL
Virology; 2013 May; 439(2):152-62. PubMed ID: 23490048
[TBL] [Abstract][Full Text] [Related]
17. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
Suresh M; Gao X; Fischer C; Miller NE; Tewari K
J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
[TBL] [Abstract][Full Text] [Related]
18. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.
Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM
J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930
[TBL] [Abstract][Full Text] [Related]
19. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
Zhou S; Ou R; Huang L; Moskophidis D
J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
[TBL] [Abstract][Full Text] [Related]
20. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
